Clinical Trial Update: Efficacy and Safety of Patupilone in Patients With Advanced Solid Tumors in Japan [Phase 1]

View source ↗

Summary

Phase 1 study update reporting safety and preliminary efficacy of patupilone in Japanese patients with advanced solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Patupilone (epothilone B)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Tumors | Phase 1 | Status: COMPLETED